Laura Soucek

Laura Soucek (born 1973) is a Group Leader at VHIO (the Vall d'Hebron Institute of Oncology), Research Professor at ICREA, and CEO of Peptomyc S.L. She works on the Myc oncoprotein, the deregulation of which occurs during almost all cancers. Soucek has designed a dominant negative variant, Omomyc, which allows her to investigate the benefits of inhibiting Myc in cancer. Provided by Wikipedia
Showing 1 - 7 results of 7 for search 'Laura Soucek', query time: 0.11s Refine Results
  1. 1
    Blocking Myc to Treat Cancer: Reflecting on Two Decades of Omomyc
    by Daniel Massó-Vallés, Laura Soucek
    Published 2020-04-01
    Get full text
    Article
  2. 2
    Structural and Biophysical Insights into the Function of the Intrinsically Disordered Myc Oncoprotein
    Get full text
    Article
  3. 3
    Live or Die: Choice Mechanisms in Stressed Cells
    Get full text
    Article
  4. 4
    Biophysical characterization of the b-HLH-LZ of ΔMax, an alternatively spliced isoform of Max found in tumor cells: Towards the validation of a tumor suppressor role for the Max homodimers.
    Get full text
    Article
  5. 5
    The action mechanism of the Myc inhibitor termed Omomyc may give clues on how to target Myc for cancer therapy.
    Get full text
    Article
  6. 6
    Modeling Pharmacological Inhibition of Mast Cell Degranulation as a Therapy for Insulinoma
    Get full text
    Article
  7. 7
    Targeting Antitumoral Proteins to Breast Cancer by Local Administration of Functional Inclusion Bodies
    Get full text
    Article
Search Tools: Get RSS Feed — Email this Search